BG105547A - Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof - Google Patents

Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof

Info

Publication number
BG105547A
BG105547A BG105547A BG10554701A BG105547A BG 105547 A BG105547 A BG 105547A BG 105547 A BG105547 A BG 105547A BG 10554701 A BG10554701 A BG 10554701A BG 105547 A BG105547 A BG 105547A
Authority
BG
Bulgaria
Prior art keywords
azithromycin
pharmaceutical compositions
ethanolate
manufacture
disclosed
Prior art date
Application number
BG105547A
Other languages
Bulgarian (bg)
English (en)
Inventor
Claude Singer
Judith Aronhime
Original Assignee
Teva Pharmaceutical Industries Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22332273&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG105547(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Pharmaceutical Industries Ltd. filed Critical Teva Pharmaceutical Industries Ltd.
Publication of BG105547A publication Critical patent/BG105547A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
BG105547A 1998-11-30 2001-05-29 Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof BG105547A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11029898P 1998-11-30 1998-11-30
PCT/US1999/028368 WO2000032203A1 (en) 1998-11-30 1999-11-30 Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof

Publications (1)

Publication Number Publication Date
BG105547A true BG105547A (en) 2001-12-31

Family

ID=22332273

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105547A BG105547A (en) 1998-11-30 2001-05-29 Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof

Country Status (26)

Country Link
US (1) US6365574B2 (pl)
EP (2) EP1152765B1 (pl)
JP (1) JP2002531409A (pl)
KR (1) KR100603226B1 (pl)
CN (2) CN1273142C (pl)
AP (1) AP1709A (pl)
AT (1) ATE279200T1 (pl)
AU (1) AU768219B2 (pl)
BG (1) BG105547A (pl)
CA (1) CA2352562A1 (pl)
CZ (1) CZ20011886A3 (pl)
DE (1) DE69921192T2 (pl)
DK (1) DK1152765T3 (pl)
ES (1) ES2229804T3 (pl)
HK (1) HK1043725B (pl)
HU (1) HUP0104241A3 (pl)
IL (1) IL143376A0 (pl)
LV (1) LV12735B (pl)
NZ (1) NZ512496A (pl)
PL (1) PL197894B1 (pl)
PT (1) PT1152765E (pl)
RO (1) RO121408B1 (pl)
RU (1) RU2240124C2 (pl)
SI (1) SI20639A (pl)
WO (1) WO2000032203A1 (pl)
ZA (1) ZA200104312B (pl)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020231A2 (en) * 2002-03-18 2003-12-31 Pliva D D ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
TW546302B (en) * 1998-05-08 2003-08-11 Biochemie Sa Improvements in macrolide production
CA2245398C (en) 1998-08-21 2002-01-29 Apotex Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
IL143376A0 (en) * 1998-11-30 2002-04-21 Teva Pharma Ethanolate of azithromycin, process for the manufacture, and pharmaceutical compositions thereof
UA76967C2 (uk) * 2000-11-27 2006-10-16 Сандоз Аг Азитроміцин у формі моногідрату, фармацевтична композиція та спосіб його одержання
HU229488B1 (hu) * 2000-11-27 2014-01-28 Sandoz Ag Eljárás makrolid hidrátok elõállítására
KR100431431B1 (ko) * 2001-04-25 2004-05-14 한미약품 주식회사 아지트로마이신 수화물의 1,2-프로필렌글리콜 내포화합물,그의 제조방법 및 그의 약학적 조성물
US6861413B2 (en) 2001-05-22 2005-03-01 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
JP2004530703A (ja) * 2001-05-22 2004-10-07 ファイザー・プロダクツ・インク 結晶形アジスロマイシン
SI1390377T1 (sl) 2001-05-22 2006-06-30 Pfizer Prod Inc Nova kristalna oblika azitromicina
EP1541134A3 (en) * 2001-10-18 2007-06-06 Teva Pharmaceutical Industries Limited Stabilized azithromycin compositions
US20080149521A9 (en) * 2001-10-18 2008-06-26 Michael Pesachovich Methods of stabilizing azithromycin
WO2003032922A2 (en) * 2001-10-18 2003-04-24 Teva Pharmaceutical Industries Ltd. Stabilized azithromycin compositions
JP2005515212A (ja) * 2001-12-21 2005-05-26 ファイザー・プロダクツ・インク アジスロマイシンの湿式造粒法
AU2002348884A1 (en) * 2001-12-21 2003-07-09 Pfizer Products Inc. Directly compressible formulations of azithromycin
KR100676025B1 (ko) * 2002-02-01 2007-01-29 화이자 프로덕츠 인코포레이티드 아지쓰로마이신의 건조 과립화 제제
HRP20020614A2 (en) * 2002-07-22 2004-06-30 PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
US20050013835A1 (en) * 2003-07-15 2005-01-20 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
US20050101547A1 (en) * 2003-11-06 2005-05-12 Sadatrezaei Mohsen Stabilized azithromycin composition
WO2005053639A2 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Controlled release multiparticulates formed with dissolution enhancers
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
EP1694304A2 (en) * 2003-12-04 2006-08-30 Pfizer Products Inc. Azithromycin multiparticulate dosage forms by liquid-based processes
EP1691786A1 (en) * 2003-12-04 2006-08-23 Pfizer Products Inc. Multiparticulate compositions with improved stability
SI1691787T1 (sl) * 2003-12-04 2008-10-31 Pfizer Prod Inc Postopek za pripravo farmacevtskih produktov iz več delcev
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
BRPI0417348A (pt) * 2003-12-04 2007-03-13 Pfizer Prod Inc processo de gelatinização por spray com utilização de uma extrusora para preparação de composições de droga cristalina multiparticulada contendo preferencialmente um poloxámero e um glicerìdeo
US7943585B2 (en) 2003-12-22 2011-05-17 Sandoz, Inc. Extended release antibiotic composition
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US7683162B2 (en) * 2004-08-30 2010-03-23 Taro Pharmaceutical Industries Limited Process of preparing a crystalline azithromycin monohydrate
JP2008524318A (ja) * 2004-12-21 2008-07-10 ファイザー・プロダクツ・インク 安定なアジスロマイシン非二水和物の経口用懸濁液剤
US20060198895A1 (en) * 2005-03-07 2006-09-07 Kotliar Eleonora M Azithromycin powder for oral suspension compositions
MX2011009548A (es) 2009-03-13 2011-12-14 Da Volterra Composiciones y metodos para la eliminacion de bacterias gram-negativas.
EP3366326A1 (en) * 2009-04-17 2018-08-29 Micell Technologies, Inc. Stents having controlled elution
WO2013088274A1 (en) 2011-12-14 2013-06-20 Wockhardt Limited Anhydrous amorphous azithromycin composition free of azithromycin dihydrate
CN103983730B (zh) * 2014-06-11 2015-09-30 北京市药品检验所 阿奇霉素或其制剂中的杂质检查方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43006B (en) 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
RO107257B1 (ro) * 1987-07-09 1993-10-30 Pfizer Procedeu de obtinere a unui dihidrat de azitromicina, cristalin
WO1989002271A1 (en) * 1987-09-10 1989-03-23 Pfizer Azithromycin and derivatives as antiprotozoal agents
CN1093370A (zh) 1993-12-10 1994-10-12 北京市集才药物研究所 一种新的阿齐红霉素结晶及其制备方法
CN1161971A (zh) * 1997-01-03 1997-10-15 石家庄制药集团有限公司 一种阿齐霉素结晶及其制备方法
CA2245398C (en) * 1998-08-21 2002-01-29 Apotex Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
IL143376A0 (en) * 1998-11-30 2002-04-21 Teva Pharma Ethanolate of azithromycin, process for the manufacture, and pharmaceutical compositions thereof
KR100491183B1 (ko) * 2001-03-21 2005-05-25 한미약품 주식회사 아지트로마이신의 제조방법 및 이 방법에 사용되는9-데옥소-9에이-아자-9에이-호모에리트로마이신 에이의결정성 수화물
JP2004530703A (ja) * 2001-05-22 2004-10-07 ファイザー・プロダクツ・インク 結晶形アジスロマイシン

Also Published As

Publication number Publication date
SI20639A (sl) 2002-02-28
CN1273142C (zh) 2006-09-06
RU2240124C2 (ru) 2004-11-20
EP1152765B1 (en) 2004-10-13
ZA200104312B (en) 2001-11-28
HK1043725B (zh) 2005-05-06
WO2000032203A1 (en) 2000-06-08
AP2001002183A0 (en) 2001-06-30
DE69921192D1 (de) 2004-11-18
LV12735B (en) 2002-03-20
RO121408B1 (ro) 2007-05-30
LV12735A (en) 2001-10-20
HK1043725A1 (en) 2002-09-27
AU768219B2 (en) 2003-12-04
ATE279200T1 (de) 2004-10-15
US6365574B2 (en) 2002-04-02
CZ20011886A3 (cs) 2001-10-17
PT1152765E (pt) 2004-12-31
HUP0104241A3 (en) 2003-12-29
DK1152765T3 (da) 2005-01-31
NZ512496A (en) 2003-02-28
CN1737008A (zh) 2006-02-22
US20020007049A1 (en) 2002-01-17
PL197894B1 (pl) 2008-05-30
KR20010099806A (ko) 2001-11-09
IL143376A0 (en) 2002-04-21
DE69921192T2 (de) 2006-02-16
CN100339384C (zh) 2007-09-26
EP1152765A4 (en) 2002-07-17
AU3106500A (en) 2000-06-19
KR100603226B1 (ko) 2006-08-28
EP1484062A1 (en) 2004-12-08
EP1152765A1 (en) 2001-11-14
JP2002531409A (ja) 2002-09-24
CA2352562A1 (en) 2000-06-08
PL347971A1 (en) 2002-05-06
HUP0104241A2 (hu) 2002-03-28
CN1334735A (zh) 2002-02-06
AP1709A (en) 2007-02-27
ES2229804T3 (es) 2005-04-16

Similar Documents

Publication Publication Date Title
BG105547A (en) Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof
BG104159A (en) Polymorphs of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid and method for their preparation
MX9707706A (es) Compuestos intermediarios novedosos y proceso para la manufactura de derivados de la camptotecina (cpt-11) y compuestos relacionados.
CA2295515A1 (en) Method for large-scale production of di(uridine 5'-tetraphosphate) and salts thereof
NZ237132A (en) Preparation of substituted oxetanones from beta-hydroxy-omega-lactones; various beta-hydroxy and beta-keto-omega-lactones
ATE302786T1 (de) Verfahren zur herstllung von clarithromycin polymorphen und polymorph iv
IL140419A0 (en) Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same
FR2847594B1 (fr) Preparation de blocs d'halogenure de terre rare
HUP0200580A2 (hu) Celecoxib polimorf kristályos formái, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
EG20726A (en) Process for preparing of galanthamine derivatives as acetylchol inc-sterase inhibitors
HUP0301862A2 (hu) Laktámvegyület, a vegyületet tartalmazó gyógyászati készítmény, eljárás elżállítására, köztitermékek és alkalmazása gyógyászati készítmény elżállítására
UA66866C2 (uk) Синтез морфолінових похідних
MY107160A (en) N-aryl-3-aryl-4-substituted-4,5-dihydro-1h-pyrazole-1- carboxamides and processes for their production.
SI1102765T1 (en) PROCESS FOR THE SYNTHESIS OF (1$i(H))-BENZO C)QUINOLIZIN-3-ONES DERIVATIVES
NZ509561A (en) Crystalline forms of osanetant
ZA200005110B (en) Process for preparing intermediates.
NO20031137L (no) Foreliggende oppfinnelse angår en fremgangsmåte for fremstilling av kiraleforbindelser under betingelsene for en 1,4-Michael-addisjon.Oppfinnelsen angårogså de tilsvarende forbindelser
BG108151A (en) Caloporoside derivatives, methods for the production thereof and their use
YU38901A (sh) Etanolat azitromicina, procesi proizvodnje i njegov farmaceutski sastav
MY120806A (en) Improved process for preparing pharmaceutically valuable norbenzomorphane derivatives.
EP0414913A4 (en) P-aminophenol derivative and production and application thereof
MY141464A (en) Method for large-scale production of di(uridine 5')-tetraphosphate and salts thereof
JPS5419985A (en) Production of hydroxycarbostyril derivative
JPS53112868A (en) Production of thienylacetic acid derivative
CO4410182A1 (es) Proceso para mejorar la pureza enantiomerica de aldehidos